Lexaria Bioscience Corp (LEXX)
2.17
+0.08
(+3.83%)
USD |
NASDAQ |
Nov 25, 16:00
2.17
0.00 (0.00%)
After-Hours: 20:00
Lexaria Bioscience Revenue (TTM): 0.411M for May 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| May 31, 2024 | 0.411M |
| February 29, 2024 | 0.4047M |
| November 30, 2023 | 0.2798M |
| August 31, 2023 | 0.2262M |
| May 31, 2023 | 0.3066M |
| February 28, 2023 | 0.3286M |
| November 30, 2022 | 0.3393M |
| August 31, 2022 | 0.2554M |
| May 31, 2022 | 0.1753M |
| February 28, 2022 | 0.2796M |
| November 30, 2021 | 0.441M |
| August 31, 2021 | 0.7227M |
| May 31, 2021 | 0.8255M |
| February 28, 2021 | 0.6578M |
| November 30, 2020 | 0.5034M |
| August 31, 2020 | 0.218M |
| May 31, 2020 | 0.2094M |
| February 29, 2020 | 0.2329M |
| November 30, 2019 | 0.2107M |
| August 31, 2019 | 0.2226M |
| May 31, 2019 | 0.1938M |
| February 28, 2019 | 0.2743M |
| November 30, 2018 | 0.4309M |
| August 31, 2018 | 0.4333M |
| May 31, 2018 | 0.3495M |
| Date | Value |
|---|---|
| February 28, 2018 | 0.2384M |
| November 30, 2017 | 0.079M |
| August 31, 2017 | 0.0636M |
| May 31, 2017 | 0.0596M |
| February 28, 2017 | 0.0366M |
| November 30, 2016 | 0.0392M |
| August 31, 2016 | 0.0407M |
| May 31, 2016 | 0.0368M |
| February 29, 2016 | 0.0378M |
| November 30, 2015 | 0.0255M |
| August 31, 2015 | |
| May 31, 2015 | |
| February 28, 2015 | |
| November 30, 2014 | |
| July 31, 2014 | -0.3926M |
| April 30, 2014 | -0.2769M |
| January 31, 2014 | -0.1914M |
| October 31, 2013 | 0.00 |
| July 31, 2013 | 1.325M |
| April 30, 2013 | 1.568M |
| January 31, 2013 | 1.460M |
| October 31, 2012 | 1.358M |
| July 31, 2012 | 1.146M |
| April 30, 2012 | 0.9787M |
| January 31, 2012 | 1.122M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.1753M
Minimum
May 2022
0.8255M
Maximum
May 2021
0.3699M
Average
0.3066M
Median
May 2023
Revenue (TTM) Benchmarks
| Aurinia Pharmaceuticals Inc | 220.36M |
| Edesa Biotech Inc | -- |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |
| ImmunoPrecise Antibodies Ltd | 17.73M |